Kura Oncology
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $17,336 | $20,750 | $15,288 | $14,108 |
Gross Profit | 16,876 | 17,538 | 15,288 | 14,108 |
EBITDA | -85,865 | -73,952 | -65,507 | -64,700 |
EBIT | -86,268 | -74,116 | -65,731 | -57,585 |
Net Income | -80,999 | -74,116 | -66,122 | -57,429 |
Net Change In Cash | 17,336 | 20,750 | 15,288 | 14,108 |
Free Cash Flow | 114,952 | -83,193 | -30,235 | -72,219 |
Cash | 149,099 | 95,287 | 81,948 | 51,269 |
Basic Shares | 88,050 | 87,645 | 87,586 | 87,415 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $67,482 | $53,883 | $0 | $0 |
Gross Profit | 67,425 | 53,883 | -849 | -759 |
EBITDA | -303,631 | -169,498 | -150,233 | -134,852 |
EBIT | -304,663 | -170,346 | -151,082 | -135,611 |
Net Income | -278,666 | -173,983 | -152,631 | -135,840 |
Net Change In Cash | 67,482 | 53,883 | 0 | 0 |
Cost of Revenue | -38,870 | |||
Free Cash Flow | -70,696 | 133,845 | -124,992 | -110,688 |
Cash | 149,099 | 224,462 | 37,318 | 51,802 |
Basic Shares | 87,676 | 86,161 | 73,229 | 66,990 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.92 |
2025-09-30 | -$0.85 |
2025-06-30 | -$0.75 |
